Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Liposarcoma, Soft Tissue Sarcoma Drug Development

Robin Jones

MD, PhD

🏢Royal Marsden Hospital / Institute of Cancer Research🌐UK

Professor, Sarcoma Medical Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Robin Jones is a leading sarcoma oncologist at the Royal Marsden who has led pivotal clinical trials in liposarcoma and soft tissue sarcomas, including studies of eribulin in advanced liposarcoma (EORTC 62091) and CDK4/6 inhibitors in CDK4-amplified liposarcomas. His research has characterized the molecular landscape of dedifferentiated liposarcoma and evaluated MDM2 antagonists. He is active in international sarcoma consortia including EORTC Soft Tissue and Bone Sarcoma Group. His work has contributed to rare histotype-specific drug approvals and the development of biomarker-driven sarcoma trials.

Share:

🧪Research Fields 研究领域

liposarcoma CDK4 amplification
palbociclib liposarcoma
MDM2 amplification dedifferentiated liposarcoma
STS clinical trials
eribulin liposarcoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Robin Jones 的研究动态

Follow Robin Jones's research updates

留下邮箱,当我们发布与 Robin Jones(Royal Marsden Hospital / Institute of Cancer Research)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment